Publishers have traditionally heard “niche” and thought small. These days they hear it and think “opportunity.”
This fall, The Boston Globe plans to launch Stat, a standalone news site focused on health, medicine and life sciences. Aimed at general-interest readers, the site’s early output has included coverage of measles vaccines, heart disease studies and crowdfunded medical devices. It’s the third of such standalone sites for the Globe, which launched its technology focused BetaBoston last March and Crux, its Catholic news site, last September.